Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT)
- Device ID
- 192304
- MHRA Reference Number
- 192304
- Date Registered
- Nov 26, 2024
- Last Updated
- May 9, 2024
- Device Type
- In Vitro Diagnostic Device
- Devices
- Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT)
- Type
- IVD General
- Name
- BIOTYPE GmbH
- Address
- Moritzburger Weg 67 Dresden, Germany
- Created Date
- Apr 26, 2024
- Name
- Qarad UK Ltd.
- Relationship Type
- UK Responsible Person
- Address
- 8 Northumberland Ave Westminster, London , England, United KingdomPostcode: WC2N 5BY
Devices with a matching generic name or device type registered with MHRA
Additional devices represented by Qarad UK Ltd. in the UK
Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 192304. The device is manufactured by BIOTYPE GmbH from Germany, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Qarad UK Ltd..
This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.